cardiovascularbusiness.com Breaking News Headlines Today | Ground News

cardiovascularbusiness.com image

News from cardiovascularbusiness.com

All of today’s top news stories from cardiovascularbusiness.com. Get the full analysis behind how media bias impacts breaking news.

We’ve aggregated 183 of cardiovascularbusiness.com’s headlines and news stories over the past 3 months.

cardiovascularbusiness.com’s media bias is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is cardiovascularbusiness.com credible or reliable? Our Factuality score answers both of those questions. When it comes to cardiovascularbusiness.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about cardiovascularbusiness.com

Where is cardiovascularbusiness.com located?cardiovascularbusiness.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top cardiovascularbusiness.com News

FDA keeps Mounjaro off shortage list after reevaluation

Diabetes · United States

FDA keeps Mounjaro off shortage list after reevaluation

50% Center coverage: 26 sources

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a reevaluation of its decision to remove it from the federal drug shortage list amid intense pushback from compounded drug manufacturers. See the Story

Recalled Pacemakers; FDA Rejects Full Andexxa Approval; Ticagrelor Back in Hot Seat

Recalled Pacemakers; FDA Rejects Full Andexxa Approval; Ticagrelor Back in Hot Seat

75% Center coverage: 4 sources

(MedPage Today) -- The FDA is alerting clinicians to a recall of Boston Scientific's Accolade pacemakers, which have an increased risk of permanently entering "safety mode," possibly requiring early device replacement. The agency also cleared...See the Story

Boston Scientific updates cryoablation catheter instructions after 4 death reports

FDA · Massachusetts

Boston Scientific updates cryoablation catheter instructions after 4 death reports

34% Center coverage: 3 sources

The update followed a higher than expected number of reports of esophageal injury after catheter ablation procedures for atrial fibrillation.See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc